[go: up one dir, main page]

CN116083329A - Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation - Google Patents

Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation Download PDF

Info

Publication number
CN116083329A
CN116083329A CN202211176997.7A CN202211176997A CN116083329A CN 116083329 A CN116083329 A CN 116083329A CN 202211176997 A CN202211176997 A CN 202211176997A CN 116083329 A CN116083329 A CN 116083329A
Authority
CN
China
Prior art keywords
gene
corynebacterium glutamicum
seq
yqhd
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211176997.7A
Other languages
Chinese (zh)
Inventor
孙宇
杨令霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Green Kangcheng Biotechnology Co ltd
Original Assignee
Beijing Green Kangcheng Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Green Kangcheng Biotechnology Co ltd filed Critical Beijing Green Kangcheng Biotechnology Co ltd
Priority to CN202211176997.7A priority Critical patent/CN116083329A/en
Publication of CN116083329A publication Critical patent/CN116083329A/en
Priority to PCT/CN2023/114599 priority patent/WO2024066822A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1288Transferases for other substituted phosphate groups (2.7.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/99Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with other acceptors (1.2.99)
    • C12Y102/99006Carboxylate reductase (1.2.99.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • C12Y206/010194-Aminobutyrate—2-oxoglutarate transaminase (2.6.1.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/08Transferases for other substituted phosphate groups (2.7.8)
    • C12Y207/08007Holo-[acyl-carrier-protein] synthase (2.7.8.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01015Glutamate decarboxylase (4.1.1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/265Micrococcus
    • C12R2001/28Micrococcus glutamicus ; Corynebacterium glutamicum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明提供一种发酵生产γ‑丁内酯或1,4‑丁二醇的方法,通过合成生物学技术,以谷氨酸棒杆菌为底盘,通过引入外源的谷氨酸脱羧酶基因gadB*突变体、醇脱氢酶基因yqhD、强化内源或外源的γ‑氨基丁酸转氨酶基因gabT,实现了利用重组微生物发酵可再生的原料如葡萄糖、蔗糖等一步发酵生产4‑羟基丁酸,再对发酵液简单加热脱羧即可获得GBL。进一步在上述微生物中引入羧酸还原酶CAR基因及磷酸泛酰巯基乙胺基转移酶基因sfp,可实现利用重组微生物直接发酵葡萄糖、蔗糖等生产BDO。本发明实现了利用可再生原料到重要化学品GBL和BDO的直接发酵生产,生产过程清洁安全,碳排放量低,具有重要的工业应用价值。The invention provides a method for fermenting and producing γ-butyrolactone or 1,4-butanediol. Through synthetic biology technology, Corynebacterium glutamicum is used as a chassis, and an exogenous glutamic acid decarboxylase gene gadB is introduced. * Mutant, alcohol dehydrogenase gene yqhD, enhanced endogenous or exogenous γ-aminobutyric acid transaminase gene gabT, realized the production of 4-hydroxybutyric acid by one-step fermentation of renewable raw materials such as glucose and sucrose by recombinant microorganisms , and then decarboxylate the fermentation broth by simple heating to obtain GBL. Further introducing the carboxylic acid reductase CAR gene and the phosphopantetheinyl transferase gene sfp into the above-mentioned microorganisms can realize the direct fermentation of glucose, sucrose and the like to produce BDO by using the recombinant microorganisms. The invention realizes the direct fermentation production of important chemicals GBL and BDO by using renewable raw materials, the production process is clean and safe, the carbon emission is low, and has important industrial application value.

Description

发酵生产γ-丁内酯或1,4-丁二醇的方法Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation

技术领域technical field

本发明属于基因工程和生物发酵技术领域,具体地说,涉及一种发酵生产γ-丁内酯或1,4-丁二醇的方法。The invention belongs to the technical field of genetic engineering and biological fermentation, and in particular relates to a method for producing gamma-butyrolactone or 1,4-butanediol by fermentation.

背景技术Background technique

1,4-丁二醇(BDO)是一种重要的有机化工和精细化工原料,被广泛用于制造各种聚酯、聚氨酯和聚醚多元醇等高分子材料,例如其是合成工程塑料聚对苯二甲酸丁二醇酯(PBT)的关键单体,同时其也是合成生物可降解材料聚丁二酸丁二醇酯(PBS)和PBAT的关键单体。近年来,随着限塑令和碳中和相关政策的出台,生物可降解材料PBS和PBAT的需求呈现井喷式发展,从而带动全球市场对BDO需求的快速增长。BDO同时也是合成四氢呋喃、γ-丁内酯等化学品的重要前体。γ-丁内酯(GBL)也是一种重要有机和医药中间体,在医药、农药、石油化工等方面有着广泛的应用,是锂电池电解液主要成分之一,同时也是合成2-吡咯烷酮、N-甲基-2-吡咯烷酮(NMP)、聚乙烯吡咯烷酮(PVP)等化学品的重要原料。1,4-Butanediol (BDO) is an important organic chemical and fine chemical raw material, which is widely used in the manufacture of various polymer materials such as polyester, polyurethane and polyether polyols. For example, it is a synthetic engineering plastic polymer It is the key monomer of butylene terephthalate (PBT), and it is also the key monomer of synthesizing biodegradable materials polybutylene succinate (PBS) and PBAT. In recent years, with the introduction of plastic restrictions and carbon neutral policies, the demand for biodegradable materials PBS and PBAT has shown a blowout development, which has driven the rapid growth of the global market demand for BDO. BDO is also an important precursor for the synthesis of tetrahydrofuran, γ-butyrolactone and other chemicals. γ-butyrolactone (GBL) is also an important organic and pharmaceutical intermediate, which is widely used in medicine, pesticide, petrochemical industry, etc. It is one of the main components of lithium battery electrolyte, and it is also a -Important raw materials for chemicals such as methyl-2-pyrrolidone (NMP) and polyvinylpyrrolidone (PVP).

目前,BDO的合成主要是通过化学法,以电石等为原料经过复杂的化学转化过程而合成,是一个极度高能耗的过程,因此开发环境友好、节能降耗的生物法技术,实现从可再生的生物质原料直接发酵生产BDO具有重要的工业应用价值。GBL的生产目前主要是以BDO为原料通过化学法生产,目前未见生物法直接合成GBL的相关报道。At present, the synthesis of BDO is mainly through chemical methods, using calcium carbide as raw materials through a complex chemical conversion process, which is an extremely high-energy-consuming process. The direct fermentation of biomass raw materials to produce BDO has important industrial application value. The production of GBL is currently mainly based on BDO as a raw material through chemical production, and there is no relevant report on the direct synthesis of GBL by biological methods.

发明内容Contents of the invention

本发明的目的是提供一种发酵生产γ-丁内酯或1,4-丁二醇的方法。The object of the present invention is to provide a method for fermentatively producing γ-butyrolactone or 1,4-butanediol.

本发明构思如下:通过合成生物学技术,以谷氨酸棒杆菌为底盘,通过在该底盘中引入外源的谷氨酸脱羧酶基因gadB*突变体、醇脱氢酶基因yqhD、强化内源或外源的γ-氨基丁酸转氨酶基因gabT,首次实现了利用重组微生物发酵可再生的原料如葡萄糖、蔗糖等一步发酵生产4-羟基丁酸,再通过对发酵液简单加热脱水即可以获得GBL。进一步在上述微生物中引入羧酸还原酶CAR基因及磷酸泛酰巯基乙胺基转移酶基因sfp,即可以实现利用重组微生物直接发酵葡萄糖、蔗糖等生产BDO。The concept of the present invention is as follows: through synthetic biology technology, using Corynebacterium glutamicum as the chassis, introducing exogenous glutamic acid decarboxylase gene gadB* mutant, alcohol dehydrogenase gene yqhD, and strengthening endogenous Or the exogenous γ-aminobutyric acid transaminase gene gabT, for the first time realized the use of recombinant microorganisms to ferment renewable raw materials such as glucose and sucrose to produce 4-hydroxybutyric acid in one step, and then simply heat and dehydrate the fermentation broth to obtain GBL . Further introducing the carboxylic acid reductase CAR gene and the phosphopantetheinyl transferase gene sfp into the above-mentioned microorganisms can realize the direct fermentation of glucose, sucrose and the like to produce BDO by using the recombinant microorganisms.

为了实现本发明目的,第一方面,本发明提供一种重组谷氨酸棒杆菌,所述重组谷氨酸棒杆菌是通过在谷氨酸棒杆菌中过表达谷氨酸脱羧酶突变体基因gadB*和醇脱氢酶基因yqhD构建得到的。In order to realize the object of the present invention, the first aspect, the present invention provides a kind of recombinant Corynebacterium glutamicum, described recombinant Corynebacterium glutamicum is by overexpressing glutamic acid decarboxylase mutant gene gadB in Corynebacterium glutamicum *Constructed with alcohol dehydrogenase gene yqhD.

本发明中,所述谷氨酸脱羧酶突变体基因gadB*和醇脱氢酶基因yqhD来源于大肠杆菌;基因gadB*和基因yqhD编码的氨基酸序列分别如SEQ ID NO:1和2所示。In the present invention, the glutamic acid decarboxylase mutant gene gadB* and the alcohol dehydrogenase gene yqhD are derived from Escherichia coli; the amino acid sequences encoded by the gene gadB* and the gene yqhD are shown in SEQ ID NO: 1 and 2, respectively.

进一步地,在所述重组谷氨酸棒杆菌中表达内源或外源的γ-氨基丁酸转氨酶基因gabT。Further, the endogenous or exogenous γ-aminobutyric acid transaminase gene gabT is expressed in the recombinant Corynebacterium glutamicum.

所述γ-氨基丁酸转氨酶基因gabT可以来源于谷氨酸棒杆菌、大肠杆菌或恶臭假单胞菌,它们编码的氨基酸序列分别如SEQ ID NO:3、SEQ ID NO:4或SEQ ID NO:5所示。The gamma-aminobutyric acid transaminase gene gabT can be derived from Corynebacterium glutamicum, Escherichia coli or Pseudomonas putida, and the amino acid sequences encoded by them are respectively as SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO :5 shown.

第二方面,本发明提供所述重组谷氨酸棒杆菌在发酵生产γ-丁内酯中的应用。In the second aspect, the present invention provides the application of the recombinant Corynebacterium glutamicum in fermentative production of γ-butyrolactone.

进一步地,利用所述重组谷氨酸棒杆菌,以廉价碳源为原料发酵生产γ-丁内酯。Further, the recombinant Corynebacterium glutamicum is used to ferment and produce γ-butyrolactone with cheap carbon source as raw material.

所述廉价碳源可选自葡萄糖、蔗糖、麦芽糖、纤维二糖等中的至少一种。The cheap carbon source can be selected from at least one of glucose, sucrose, maltose, cellobiose and the like.

第三方面,本发明提供一种谷氨酸棒杆菌工程菌,所述工程菌是在所述重组谷氨酸棒杆菌中表达羧酸还原酶CAR基因及磷酸泛酰巯基乙胺基转移酶基因sfp构建得到的。In a third aspect, the present invention provides a Corynebacterium glutamicum engineering bacterium, and the engineering bacterium expresses the carboxylic acid reductase CAR gene and the phosphopantetheinyl transferase gene in the recombinant Corynebacterium glutamicum sfp build got.

所述羧酸还原酶CAR基因可以来源于Mycobacterium marinum、Nocardiaiowensis、Mycolicibacterium smegmatis或Mycobacteroides abscessus,它们编码的氨基酸序列分别如SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8或SEQ ID NO:9所示。The carboxylic acid reductase CAR gene can be derived from Mycobacterium marinum, Nocardiaiowensis, Mycolicibacterium smegmatis or Mycobacteroides abscessus, and the amino acid sequences encoded by them are respectively as SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8 or SEQ ID NO : as shown in 9.

所述磷酸泛酰巯基乙胺基转移酶基因sfp可以来源于枯草芽胞杆菌,其编码的氨基酸序列如SEQ ID NO:10所示。The phosphopantetheinyl transferase gene sfp can be derived from Bacillus subtilis, and its encoded amino acid sequence is shown in SEQ ID NO:10.

第四方面,本发明提供所述谷氨酸棒杆菌工程菌在发酵生产1,4-丁二醇中的应用。In the fourth aspect, the present invention provides the application of the Corynebacterium glutamicum engineering bacteria in the fermentative production of 1,4-butanediol.

进一步地,利用所述谷氨酸棒杆菌工程菌,以廉价碳源为原料发酵生产γ-丁内酯。Further, the Corynebacterium glutamicum engineering bacteria are used to ferment and produce γ-butyrolactone with cheap carbon sources as raw materials.

所述廉价碳源可选自葡萄糖、蔗糖、麦芽糖、纤维二糖等中的至少一种。The cheap carbon source can be selected from at least one of glucose, sucrose, maltose, cellobiose and the like.

第五方面,本发明提供一种谷氨酸脱羧酶突变体,其氨基酸序列如SEQ ID NO:1所示。In a fifth aspect, the present invention provides a glutamic acid decarboxylase mutant whose amino acid sequence is shown in SEQ ID NO:1.

第六方面,本发明提供所述重组谷氨酸棒杆菌及所述谷氨酸棒杆菌工程菌的构建方法,可采用常规的基因工程方法对上述基因进行改造或修饰。In the sixth aspect, the present invention provides a method for constructing the recombinant Corynebacterium glutamicum and the Corynebacterium glutamicum engineering bacterium, and the above-mentioned genes can be transformed or modified by conventional genetic engineering methods.

借由上述技术方案,本发明至少具有下列优点及有益效果:By virtue of the above technical solutions, the present invention has at least the following advantages and beneficial effects:

本发明主要通过合成生物学技术,以谷氨酸棒杆菌为底盘,通过在该底盘中引入外源的谷氨酸脱羧酶基因gadB*突变体、醇脱氢酶基因yqhD、强化内源或外源的γ-氨基丁酸转氨酶基因gabT,开创性地实现了利用重组微生物发酵可再生的原料如葡萄糖、蔗糖等一步发酵生产4-羟基丁酸,再通过对发酵液简单加热脱羧即可以获得GBL。进一步在上述微生物中引入羧酸还原酶CAR基因及磷酸泛酰巯基乙胺基转移酶基因sfp,即可以实现利用重组微生物直接发酵葡萄糖、蔗糖等生产BDO。本发明实现了利用可再生原料到重要化学品GBL和BDO的直接发酵生产,生产过程清洁安全,碳排放比化学法降低60%以上,具有重要的工业应用价值。The present invention mainly adopts synthetic biology technology, uses Corynebacterium glutamicum as the chassis, and introduces exogenous glutamic acid decarboxylase gene gadB* mutant, alcohol dehydrogenase gene yqhD into the chassis, and strengthens endogenous or exogenous The original γ-aminobutyric acid transaminase gene gabT has pioneered the use of recombinant microorganisms to ferment renewable raw materials such as glucose and sucrose to produce 4-hydroxybutyric acid in one step, and then simply heat and decarboxylate the fermentation broth to obtain GBL . Further introducing the carboxylic acid reductase CAR gene and the phosphopantetheinyl transferase gene sfp into the above-mentioned microorganisms can realize the direct fermentation of glucose, sucrose and the like to produce BDO by using the recombinant microorganisms. The invention realizes the direct fermentation production of important chemicals GBL and BDO by using renewable raw materials, the production process is clean and safe, and the carbon emission is reduced by more than 60% compared with the chemical method, and has important industrial application value.

具体实施方式Detailed ways

以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别指明,实施例均按照常规实验条件,如Sambrook等分子克隆实验手册(Sambrook J&Russell DW,Molecular Cloning:a Laboratory Manual,2001),或按照制造厂商说明书建议的条件。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the examples are all in accordance with conventional experimental conditions, such as Sambrook et al. Molecular Cloning Experiment Manual (Sambrook J & Russell DW, Molecular Cloning: a Laboratory Manual, 2001), or in accordance with the conditions suggested by the manufacturer's instructions.

实施例1生产GBL的重组谷氨酸棒杆菌的构建方法Embodiment 1 produces the construction method of the recombinant Corynebacterium glutamicum of GBL

自然界没有微生物能够天然合成GBL。本发明通过在谷氨酸棒杆菌中引入谷氨酸脱羧酶gabB*,使得谷氨酸棒杆菌产生的谷氨酸首先被转化为γ-氨基丁酸,后者在自身或者外源引入的γ-氨基丁酸转氨酶gabT和外源引入的醇脱氢酶yqhD作用下进一步转化为4-羟基丁酸,发酵液中的4-羟基丁酸在酸催化下产生GBL。There are no microorganisms in nature that can synthesize GBL naturally. In the present invention, by introducing glutamic acid decarboxylase gabB* into Corynebacterium glutamicum, the glutamic acid produced by Corynebacterium glutamicum is first converted into γ-aminobutyric acid, and the latter is converted into γ-aminobutyric acid by itself or exogenously introduced γ-aminobutyric acid. -Aminobutyric acid transaminase gabT and exogenously introduced alcohol dehydrogenase yqhD are further converted into 4-hydroxybutyric acid, and 4-hydroxybutyric acid in the fermentation broth produces GBL under acid catalysis.

人工合成大肠杆菌的谷氨酸脱羧酶gabB*的基因片段(氨基酸序列如SEQ ID NO:1所示,基因序列如SEQ ID NO:11所示)。与野生型的谷氨酸脱羧酶相比,该谷氨酸脱羧酶具有在中性pH条件下更高的活性。以该基因片段为模板,以gadB-F(5′-attaagcttgcatgcctgcactttaagaaggagatataccatggataagaagcaagtaacg-3′)和gabB-R(5′-ggtatatctccttcttaaagttagtgatcgctgagatatt-3′)为引物进行PCR,获得约1.4kb的gabB片段并进行PCR纯化。以大肠杆菌MG1655的基因组为模板,以yqhD-F(5′-ctttaagaaggagatataccatgaacaactttaatctgcac-3′)和yqhD-R(5′-ggtacccggggatcctctagttagcgggcggcttcgtata-3′)为引物进行PCR,获得约1.2kb的yqhD片段并进行PCR纯化。将pXMJ19质粒(购自Addgene)用PstI和XbaI进行双酶切,利用Gibson Assembly试剂盒(NEB)将上述纯化获得的gabB片段和yqhD片段一步连接到pXMJ19上,获得的重组质粒命名为pXMJ-gabB-yqhD。The gene fragment of glutamic acid decarboxylase gabB* of Escherichia coli is artificially synthesized (the amino acid sequence is shown in SEQ ID NO: 1, and the gene sequence is shown in SEQ ID NO: 11). Compared with wild-type glutamic acid decarboxylase, the glutamic acid decarboxylase has higher activity under neutral pH conditions. Using the gene fragment as a template, PCR was performed with gabB-F (5'-attaagcttgcatgcctgcactttaagaaggagatataccatggataagaagcaagtaacg-3') and gabB-R (5'-ggtatatctccttcttaaagttagtgatcgctgagatatt-3') primers to obtain a gabB fragment of about 1.4 kb and perform PCR purification. Using the genome of Escherichia coli MG1655 as a template, PCR was performed with yqhD-F (5′-ctttaagaaggagatataccatgaacaactttaatctgcac-3′) and yqhD-R (5′-ggtacccggggatcctctagttagcgggcggcttcgtata-3′) as primers to obtain a yqhD fragment of about 1.2 kb and perform PCR purification. The pXMJ19 plasmid (purchased from Addgene) was double digested with PstI and XbaI, and the gabB fragment and yqhD fragment obtained above were ligated to pXMJ19 in one step using the Gibson Assembly kit (NEB), and the obtained recombinant plasmid was named pXMJ-gabB -yqhD.

以谷氨酸棒杆菌的基因组为模板,以gabT_cg-F(5′-ggatccccgggtaccgagctctttaagaaggagatataccgtggaagatctctcataccg-3′)和gabT_cg-R(5′-caaaacagccaagctgaattttagcccaccttctggtgcg-3′)为引物进行PCR,获得约1.35kb的gabT_cg片段并进行PCR纯化。以大肠杆菌MG1655的基因组为模板,以gabT_ec-F(5′-ggatccccgggtaccgagctctttaagaaggagatataccatgaacagcaataaagagtt-3′)和gabT_ec-R(5′-caaaacagccaagctgaattctactgcttcgcctcatcaa-3′)为引物进行PCR,获得约1.35kb的gabT_ec片段并进行PCR纯化。以恶臭假单胞杆菌的基因组为模板,以引物gabT_pp-F(5′-ggatccccgggtaccgagctctttaagaaggagatataccatgagcaagaccaacgaatc-3′)和gabT_pp-R(5′-caaaacagccaagctgaatttcaggcaagttcagcgaagc-3′)为引物进行PCR,获得约1.35kb的gabT_pp片段并进行PCR纯化。将质粒pXMJ-gabB-yqhD用KpnI和EcoRI进行双酶切,将上述纯化获得的gabT_cg片段、gabT_ec片段、gabT_pp片段分别利用Gibson Assembly试剂盒(NEB)连接到pXMJ-gabB-yqhD上,获得的重组质粒命名分别为pXMJ-gabB-yqhD-gabT_cg、pXMJ-gabB-yqhD-gabT_ec和pXMJ-gabB-yqhD-gabT_pp。Using the genome of Corynebacterium glutamicum as a template, PCR was performed with gabT_cg-F (5′-ggatccccgggtaccgagctctttaagaaggagatataccgtggaagatctctcataccg-3′) and gabT_cg-R (5′-caaaacagccaagctgaattttagcccaccttctggtgcg-3′) as primers to obtain a gab of about 1.35 kb T_cg fragment and Perform PCR purification. Using the genome of Escherichia coli MG1655 as a template, PCR was performed with gabT_ec-F (5′-ggatccccgggtaccgagctctttaagaaggagatataccatgaacagcaataaagagtt-3′) and gabT_ec-R (5′-caaaacagccaagctgaattctactgcttcgcctcatcaa-3′) as primers to obtain about 1.35kb gab T_ec fragment and perform PCR purification. Using the genome of Pseudomonas putida as a template, the primers gabT_pp-F (5′-ggatccccgggtaccgagctctttaagaaggagatataccatgagcaagaccaacgaatc-3′) and gabT_pp-R (5′-caaaacagccaagctgaatttcaggcaagttcagcgaagc-3′) were used as primers to perform PCR to obtain about 1.35kb gab T_pp fragment And perform PCR purification. The plasmid pXMJ-gabB-yqhD was double digested with KpnI and EcoRI, and the gabT_cg fragment, gabT_ec fragment, and gabT_pp fragment obtained from the above purification were respectively connected to pXMJ-gabB-yqhD using the Gibson Assembly kit (NEB), and the obtained recombinant The plasmids were named pXMJ-gabB-yqhD-gabT_cg, pXMJ-gabB-yqhD-gabT_ec and pXMJ-gabB-yqhD-gabT_pp, respectively.

通过电转化将质粒pXMJ-gabB-yqhD、pXMJ-gabB-yqhD-gabT_cg、pXMJ-gabB-yqhD-gabT_ec、和pXMJ-gabB-yqhD-gabT_pp转入到谷氨酸棒杆菌S9114中,在含10mg/L的氯霉素LB平板上筛选获得重组菌,分别命名为S9114/pXMJ-gabB-yqhD、S9114/pXMJ-gabB-yqhD-gabT_cg、S9114/pXMJ-gabB-yqhD-gabT_ec和S9114/pXMJ-gabB-yqhD-gabT_pp。同时将pXMJ19空质粒也转入到谷氨酸棒杆菌S9114中,获得对照菌株S9114/pXMJ。Plasmids pXMJ-gabB-yqhD, pXMJ-gabB-yqhD-gabT_cg, pXMJ-gabB-yqhD-gabT_ec, and pXMJ-gabB-yqhD-gabT_pp were transferred into Corynebacterium glutamicum S9114 by electroporation, in the presence of 10 mg/ The recombinant bacteria were screened on the chloramphenicol LB plate of L and named as S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec and S9114/pXMJ-gabB- yqhD-gabT_pp. At the same time, the pXMJ19 empty plasmid was also transformed into Corynebacterium glutamicum S9114 to obtain the control strain S9114/pXMJ.

实施例2利用廉价糖原料发酵生产GBLExample 2 Production of GBL by Fermentation of Cheap Sugar Raw Materials

将菌株S9114/pXMJ-gabB-yqhD、S9114/pXMJ-gabB-yqhD-gabT_cg、S9114/pXMJ-gabB-yqhD-gabT_ec、S9114/pXMJ-gabB-yqhD-gabT_pp和对照菌株S9114/pXMJ接种到5L发酵罐中进行培养,发酵液的初始体积为2L,发酵温度为30℃,通气量为1vvm,发酵过程通过调整转速使得发酵过程的溶氧值维持在20%,通过自动流加25%氨水控制发酵液的pH为7.0,发酵4h时添加0.1mM IPTG进行诱导,发酵时间为48h。The strain S9114/PXMJ-Gabb-YQHD, S9114/PXMJ-Gabb-Yqhd-Gabt_cg, S9114/PXMJ-Gabb-Yqhd-Gabt_EC, S9114/PXMJ-Gabb-Gabt_pp and the control strain S9114 /pxmj to inoculate to 5L fermentation tank The initial volume of the fermentation broth is 2L, the fermentation temperature is 30°C, and the ventilation volume is 1vvm. During the fermentation process, the dissolved oxygen value in the fermentation process is maintained at 20% by adjusting the rotation speed, and the fermentation broth is controlled by automatically adding 25% ammonia water. The pH was 7.0, and 0.1mM IPTG was added for induction after 4 hours of fermentation, and the fermentation time was 48 hours.

发酵培养基配方包括(g/L):葡萄糖100,(NH4)2SO4 20,K2HPO4 1.0,MgSO4 0.5,MnSO4 0.2,FeSO4 0.2,玉米浆20,磷酸吡哆醛0.01,盐酸硫胺素0.001,氯霉素0.005。Fermentation medium formula includes (g/L): glucose 100, (NH 4 ) 2 SO 4 20, K 2 HPO 4 1.0, MgSO 4 0.5, MnSO 4 0.2, FeSO 4 0.2, corn steep liquor 20, pyridoxal phosphate 0.01 , thiamine hydrochloride 0.001, chloramphenicol 0.005.

发酵48小时后停止发酵,在发酵液中加入浓HCl将pH值调整到0.8,在室温下反应24h,然后利用高效液相色谱(HPLC)检测菌株的产物。菌株S9114/pXMJ-gabB-yqhD、S9114/pXMJ-gabB-yqhD-gabT_cg、S9114/pXMJ-gabB-yqhD-gabT_ec、S9114/pXMJ-gabB-yqhD-gabT_pp分别可以生产7.2g/L、11.3g/L、14.1g/L、13.7g/L的GBL,而对照菌株S9114/pXMJ不产GBL。说明在谷氨酸棒杆菌中引入人工途径可以成功实现葡萄糖到GBL的高效生产。Stop the fermentation after 48 hours of fermentation, add concentrated HCl to the fermentation broth to adjust the pH value to 0.8, react at room temperature for 24 hours, and then use high performance liquid chromatography (HPLC) to detect the product of the strain. Strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp can produce 7.2g/L and 11.3g/L, respectively , 14.1g/L, 13.7g/L of GBL, while the control strain S9114/pXMJ did not produce GBL. It shows that the introduction of artificial pathway in Corynebacterium glutamicum can successfully realize the efficient production of glucose to GBL.

将发酵培养基的碳源从100g/L葡萄糖改为100g/L蔗糖,其他成分不变,发酵过程也保持完全一致。菌株S9114/pXMJ-gabB-yqhD、S9114/pXMJ-gabB-yqhD-gabT_cg、S9114/pXMJ-gabB-yqhD-gabT_ec、S9114/pXMJ-gabB-yqhD-gabT_pp分别可以生产7.4g/L、10.2g/L、13.3g/L、12.9g/L的GBL,而对照菌株S9114/pXMJ不产GBL。说明在谷氨酸棒杆菌中引入人工途径可以成功实现蔗糖到GBL的高效生产。The carbon source of the fermentation medium was changed from 100g/L glucose to 100g/L sucrose, other components remained unchanged, and the fermentation process remained completely the same. Strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp can produce 7.4g/L and 10.2g/L, respectively , 13.3g/L, 12.9g/L of GBL, while the control strain S9114/pXMJ did not produce GBL. It shows that the introduction of artificial pathways in Corynebacterium glutamicum can successfully achieve the efficient production of sucrose to GBL.

将发酵培养基的碳源从100g/L葡萄糖改为糖蜜(其中蔗糖含量为100g/L),其他成分不变,发酵过程也保持完全一致。菌株S9114/pXMJ-gabB-yqhD、S9114/pXMJ-gabB-yqhD-gabT_cg、S9114/pXMJ-gabB-yqhD-gabT_ec、S9114/pXMJ-gabB-yqhD-gabT_pp分别可以生产6.7g/L、9.9g/L、12.1g/L、11.7g/L的GBL,而对照菌株S9114/pXMJ不产GBL。说明在谷氨酸棒杆菌中引入人工途径可以成功实现糖蜜到GBL的高效生产。The carbon source of the fermentation medium is changed from 100g/L glucose to molasses (wherein the sucrose content is 100g/L), other components remain unchanged, and the fermentation process also remains completely consistent. Strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp can produce 6.7g/L and 9.9g/L, respectively , 12.1g/L, 11.7g/L of GBL, while the control strain S9114/pXMJ did not produce GBL. It shows that the introduction of artificial pathways in Corynebacterium glutamicum can successfully achieve the efficient production of molasses to GBL.

实施例3生产BDO的重组谷氨酸棒杆菌的构建方法Embodiment 3 produces the construction method of the recombinant Corynebacterium glutamicum of BDO

上述构建的菌株可以高效转化葡萄糖、蔗糖、糖蜜等廉价碳源生产GBL。本发明进一步通过引入羧酸还原酶,将GBL的前体4-羟基丁酸转化为BDO,从而实现利用廉价碳源直接发酵生产BDO。The strain constructed above can efficiently transform cheap carbon sources such as glucose, sucrose, and molasses to produce GBL. The invention further converts 4-hydroxybutyric acid, the precursor of GBL, into BDO by introducing carboxylic acid reductase, so as to realize the direct fermentation and production of BDO by using cheap carbon sources.

人工合成枯草芽胞杆菌的磷酸泛酰巯基乙胺基转移酶基因sfp(氨基酸序列如SEQID NO:10所示,基因序列如SEQ ID NO:20所示),该酶的主要功能是激活羧酸还原酶。以该基因片段为模板,以sfp-F(5′-atcctctagagtcgacctgcactttaagaaggagatataccaatgaaaatttacggcatcta-3′)和sfp-R(5′-cagtgccaagcttgcatgcctcaaagtaactcctcgtagg-3′)为引物进行PCR,获得约0.7kb的sfp片段并进行PCR纯化。将pEC-K18mob质粒(购自Addgene)用PstI进行单酶切,利用Gibson Assembly试剂盒(NEB)将上述纯化获得的sfp片段一步连接到pEC-K18mob上,获得的重组质粒命名为pEC-sfp。Artificially synthesized phosphopantetheinyl transferase gene sfp of Bacillus subtilis (the amino acid sequence is shown in SEQ ID NO: 10, and the gene sequence is shown in SEQ ID NO: 20), the main function of the enzyme is to activate carboxylic acid reduction enzyme. Using the gene fragment as a template, PCR was performed with primers sfp-F (5′-atcctctagagtcgacctgcactttaagaaggagatataccaatgaaaatttacggcatcta-3′) and sfp-R (5′-cagtgccaagcttgcatgcctcaaagtaactcctcgtagg-3′) to obtain a sfp fragment of about 0.7 kb and perform PCR purification. The pEC-K18mob plasmid (purchased from Addgene) was single-digested with PstI, and the sfp fragment obtained above was ligated to pEC-K18mob in one step using the Gibson Assembly kit (NEB), and the obtained recombinant plasmid was named pEC-sfp.

人工合成来源于Mycobacterium marinum、Nocardia iowensis、Mycolicibacterium smegmatis、Mycobacteroides abscessus的羧酸还原酶基因Car_mm、Car_ni、Car_ms、Car_ma(氨基酸序列分别如SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8、SEQID NO:9所示,核苷酸序列分别为SEQ ID NO:16、SEQ ID NO:17、SEQ ID NO:18、SEQ ID NO:19所示)。将质粒pEC-sfp用EcoRI和KpnI进行双酶切,将上述合成的四个基因片段分别插入到质粒pEC-sfp里,获得的质粒分别命名为pEC-Car_mm-sfp、pEC-Car_ni-sfp、pEC-Car_ms-sfp、pEC-Car_ma-sfp。将质粒pEC-Car_mm-sfp、pEC-Car_ni-sfp、pEC-Car_ms-sfp、pEC-Car_ma-sfp分别转化到谷氨酸棒杆菌菌株S9114/pXMJ-gabB-yqhD-gabT_ec,获得的重组菌株分别命名为S9114-X-MM、S9114-X-NI、S9114-X-MS、S9114-X-MA。Carboxylate reductase genes Car_mm, Car_ni, Car_ms, and Car_ma derived from Mycobacterium marinum, Nocardia iowensis, Mycolicibacterium smegmatis, and Mycobacteroides abscessus (amino acid sequences are shown in SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8, respectively) , SEQ ID NO: 9, the nucleotide sequences are shown in SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19 respectively). The plasmid pEC-sfp was double digested with EcoRI and KpnI, and the four gene fragments synthesized above were respectively inserted into the plasmid pEC-sfp, and the obtained plasmids were named pEC-Car_mm-sfp, pEC-Car_ni-sfp, pEC -Car_ms-sfp, pEC-Car_ma-sfp. The plasmids pEC-Car_mm-sfp, pEC-Car_ni-sfp, pEC-Car_ms-sfp, and pEC-Car_ma-sfp were transformed into Corynebacterium glutamicum strain S9114/pXMJ-gabB-yqhD-gabT_ec respectively, and the obtained recombinant strains were named respectively For S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA.

将菌株S9114-X-MM、S9114-X-NI、S9114-X-MS、S9114-X-MA和对照菌株S9114/pXMJ-gabB-yqhD-gabT_ec、S9114/pXMJ接种到5L发酵罐中进行培养,发酵液的初始体积为2L,发酵温度为30℃,通气量为1vvm,发酵过程通过调整转速使得发酵过程的溶氧值维持在20%,通过自动流加25%氨水控制发酵液的pH为7.0,发酵4h时添加0.1m MIPTG进行诱导,发酵时间为48h。Bacterial strains S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA and control bacterial strains S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ were inoculated into a 5L fermenter for cultivation, The initial volume of the fermentation broth is 2L, the fermentation temperature is 30°C, and the ventilation rate is 1vvm. During the fermentation process, the dissolved oxygen value during the fermentation process is maintained at 20% by adjusting the rotation speed, and the pH of the fermentation broth is controlled to 7.0 by automatically adding 25% ammonia water. , adding 0.1m MIPTG for induction at 4 hours of fermentation, and the fermentation time was 48 hours.

发酵培养基配方包括(g/L):葡萄糖100,(NH4)2SO4 20,K2HPO4 1.0,MgSO4 0.5,MnSO4 0.2,FeSO4 0.2,玉米浆20,磷酸吡哆醛0.01,盐酸硫胺素0.001,氯霉素0.005。Fermentation medium formula includes (g/L): glucose 100, (NH 4 ) 2 SO 4 20, K 2 HPO 4 1.0, MgSO 4 0.5, MnSO 4 0.2, FeSO 4 0.2, corn steep liquor 20, pyridoxal phosphate 0.01 , Thiamine hydrochloride 0.001, chloramphenicol 0.005.

发酵48小时后停止发酵,然后利用高效液相色谱(HPLC)检测菌株的产物。菌株S9114-X-MM、S9114-X-NI、S9114-X-MS、S9114-X-MA分别可以生产7.8g/L、6.9g/L、7.2g/L、7.7g/L的BDO,而对照菌株S9114/pXMJ-gabB-yqhD-gabT_ec和S9114/pXMJ均不产BDO。说明在谷氨酸棒杆菌中引入人工途径可以成功实现葡萄糖到BDO的高效生产。After 48 hours of fermentation, the fermentation was stopped, and the products of the strains were detected by high performance liquid chromatography (HPLC). Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, and S9114-X-MA could produce 7.8g/L, 6.9g/L, 7.2g/L, and 7.7g/L of BDO, respectively, while The control strains S9114/pXMJ-gabB-yqhD-gabT_ec and S9114/pXMJ did not produce BDO. It shows that the introduction of artificial pathway in Corynebacterium glutamicum can successfully realize the efficient production of glucose to BDO.

将发酵培养基的碳源从100g/L葡萄糖改为100g/L蔗糖,其他成分不变,发酵过程也保持完全一致。菌株S9114-X-MM、S9114-X-NI、S9114-X-MS、S9114-X-MA分别可以生产6.4g/L、6.2g/L、6.3g/L、6.9g/L的BDO,而对照菌株S9114/pXMJ-gabB-yqhD-gabT_ec和S9114/pXMJ均不产BDO。说明在谷氨酸棒杆菌中引入人工途径可以成功实现蔗糖到BDO的高效生产。The carbon source of the fermentation medium was changed from 100g/L glucose to 100g/L sucrose, other components remained unchanged, and the fermentation process remained completely the same. Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, and S9114-X-MA could produce 6.4g/L, 6.2g/L, 6.3g/L, and 6.9g/L of BDO, respectively, while The control strains S9114/pXMJ-gabB-yqhD-gabT_ec and S9114/pXMJ did not produce BDO. It shows that the introduction of artificial pathway in Corynebacterium glutamicum can successfully realize the efficient production of sucrose to BDO.

将发酵培养基的碳源从100g/L葡萄糖改为糖蜜(其中蔗糖含量为100g/L),其他成分不变,发酵过程也保持完全一致。菌株S9114-X-MM、S9114-X-NI、S9114-X-MS、S9114-X-MA分别可以生产5.7g/L、5.9g/L、5.1g/L、4.7g/L的BDO,而对照菌株S9114/pXMJ-gabB-yqhD-gabT_ec和S9114/pXMJ均不产BDO。说明在谷氨酸棒杆菌中引入人工途径可以成功实现糖蜜到BDO的高效生产。The carbon source of the fermentation medium is changed from 100g/L glucose to molasses (wherein the sucrose content is 100g/L), other components remain unchanged, and the fermentation process also remains completely consistent. Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, and S9114-X-MA could produce 5.7g/L, 5.9g/L, 5.1g/L, and 4.7g/L of BDO, respectively, while The control strains S9114/pXMJ-gabB-yqhD-gabT_ec and S9114/pXMJ did not produce BDO. It shows that the introduction of artificial pathway in Corynebacterium glutamicum can successfully realize the efficient production of molasses to BDO.

虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之做一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.

Claims (10)

1.重组谷氨酸棒杆菌,其特征在于,所述重组谷氨酸棒杆菌是通过在谷氨酸棒杆菌中过表达谷氨酸脱羧酶突变体基因gadB*和醇脱氢酶基因yqhD构建得到的;1. Recombinant Corynebacterium glutamicum, characterized in that, said recombinant Corynebacterium glutamicum is constructed by overexpressing glutamic acid decarboxylase mutant gene gadB* and alcohol dehydrogenase gene yqhD in Corynebacterium glutamicum owned; 所述谷氨酸脱羧酶突变体基因gadB*和醇脱氢酶基因yqhD来源于大肠杆菌;基因gadB*和基因yqhD编码的氨基酸序列分别如SEQ ID NO:1和2所示。The glutamic acid decarboxylase mutant gene gadB* and the alcohol dehydrogenase gene yqhD are derived from Escherichia coli; the amino acid sequences encoded by the gene gadB* and the gene yqhD are shown in SEQ ID NO: 1 and 2, respectively. 2.根据权利要求1所述的重组谷氨酸棒杆菌,其特征在于,进一步在所述重组谷氨酸棒杆菌中表达内源或外源的γ-氨基丁酸转氨酶基因gabT。2. The recombinant Corynebacterium glutamicum according to claim 1, characterized in that, the endogenous or exogenous γ-aminobutyric acid transaminase gene gabT is further expressed in the recombinant Corynebacterium glutamicum. 3.根据权利要求2所述的重组谷氨酸棒杆菌,其特征在于,所述γ-氨基丁酸转氨酶基因gabT来源于谷氨酸棒杆菌、大肠杆菌或恶臭假单胞菌,它们编码的氨基酸序列分别如SEQID NO:3、SEQ ID NO:4或SEQ ID NO:5所示。3. recombinant Corynebacterium glutamicum according to claim 2, is characterized in that, described gamma-aminobutyric acid transaminase gene gabT is derived from Corynebacterium glutamicum, Escherichia coli or Pseudomonas putida, and their encoded The amino acid sequences are respectively shown in SEQ ID NO:3, SEQ ID NO:4 or SEQ ID NO:5. 4.权利要求1-3任一项所述重组谷氨酸棒杆菌在发酵生产γ-丁内酯中的应用。4. The application of the recombinant Corynebacterium glutamicum described in any one of claims 1-3 in the fermentative production of γ-butyrolactone. 5.根据权利要求4所述的应用,其特征在于,以廉价碳源为原料发酵生产γ-丁内酯;5. The application according to claim 4, characterized in that, fermenting and producing gamma-butyrolactone from a cheap carbon source; 所述廉价碳源选自葡萄糖、蔗糖、麦芽糖、纤维二糖中的至少一种。The cheap carbon source is at least one selected from glucose, sucrose, maltose and cellobiose. 6.谷氨酸棒杆菌工程菌,其特征在于,所述工程菌是在权利要求1-3任一项所述重组谷氨酸棒杆菌中表达羧酸还原酶CAR基因及磷酸泛酰巯基乙胺基转移酶基因sfp构建得到的。6. Corynebacterium glutamicum engineering bacterium, it is characterized in that, described engineering bacterium expresses carboxylic acid reductase CAR gene and phosphopantethein in the recombinant Corynebacterium glutamicum described in any one of claim 1-3 Aminotransferase gene sfp was constructed. 7.根据权利要求6所述的工程菌,其特征在于,所述羧酸还原酶CAR基因来源于Mycobacterium marinum、Nocardia iowensis、Mycolicibacterium smegmatis或Mycobacteroides abscessus,它们编码的氨基酸序列分别如SEQ ID NO:6、SEQ ID NO:7、SEQ ID NO:8或SEQ ID NO:9所示;和/或7. The engineering bacterium according to claim 6, wherein the carboxylic acid reductase CAR gene is derived from Mycobacterium marinum, Nocardia iowensis, Mycolicibacterium smegmatis or Mycobacteroides abscessus, and the amino acid sequences encoded by them are respectively as SEQ ID NO:6 , SEQ ID NO:7, SEQ ID NO:8 or SEQ ID NO:9; and/or 所述磷酸泛酰巯基乙胺基转移酶基因sfp来源于枯草芽胞杆菌,其编码的氨基酸序列如SEQ ID NO:10所示。The phosphopantetheinyl transferase gene sfp is derived from Bacillus subtilis, and its encoded amino acid sequence is shown in SEQ ID NO:10. 8.权利要求6或7所述工程菌在发酵生产1,4-丁二醇中的应用。8. the application of the engineering bacterium described in claim 6 or 7 in fermentative production of 1,4-butanediol. 9.根据权利要求8所述的应用,其特征在于,以廉价碳源为原料发酵生产1,4-丁二醇;9. The application according to claim 8, characterized in that 1,4-butanediol is fermented from a cheap carbon source as a raw material; 所述廉价碳源选自葡萄糖、蔗糖、麦芽糖、纤维二糖中的至少一种。The cheap carbon source is at least one selected from glucose, sucrose, maltose and cellobiose. 10.谷氨酸脱羧酶突变体,其特征在于,其氨基酸序列如SEQ ID NO:1所示。10. Glutamic acid decarboxylase mutant, is characterized in that, its aminoacid sequence is as shown in SEQ ID NO:1.
CN202211176997.7A 2022-09-26 2022-09-26 Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation Pending CN116083329A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202211176997.7A CN116083329A (en) 2022-09-26 2022-09-26 Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation
PCT/CN2023/114599 WO2024066822A1 (en) 2022-09-26 2023-08-24 METHOD FOR PRODUCING γ-BUTYROLACTONE OR 1,4-BUTANEDIOL BY FERMENTATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211176997.7A CN116083329A (en) 2022-09-26 2022-09-26 Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation

Publications (1)

Publication Number Publication Date
CN116083329A true CN116083329A (en) 2023-05-09

Family

ID=86199810

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211176997.7A Pending CN116083329A (en) 2022-09-26 2022-09-26 Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation

Country Status (2)

Country Link
CN (1) CN116083329A (en)
WO (1) WO2024066822A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117089507A (en) * 2023-09-28 2023-11-21 北京化工大学 A genetically engineered Escherichia coli strain that uses cheap carbon sources to synthesize 1,4-butanediol and its application
WO2024066822A1 (en) * 2022-09-26 2024-04-04 北京绿色康成生物技术有限公司 METHOD FOR PRODUCING γ-BUTYROLACTONE OR 1,4-BUTANEDIOL BY FERMENTATION
WO2025135685A1 (en) * 2023-12-21 2025-06-26 대상 주식회사 Mutant microorganism having improved ability to produce 1,4-butanediol and method for producing 1,4-butanediol using same
WO2025136008A1 (en) * 2023-12-21 2025-06-26 대상 주식회사 Mutant microorganism having improved ability to produce 1,4-butanediol and method for producing 1,4-butanediol using same

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101668861A (en) * 2007-03-16 2010-03-10 基因组股份公司 compositions and methods for the biosynthesis of 1,4-butanediol and its precursors
US20100112654A1 (en) * 2008-09-10 2010-05-06 Burk Mark J Microorganisms for the production of 1,4-butanediol
US20110014669A1 (en) * 2009-01-23 2011-01-20 Microbia, Inc. Production of 1,4 Butanediol in a Microorganism
US20110129899A1 (en) * 2009-10-13 2011-06-02 Robert Haselbeck Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto
CN102498215A (en) * 2009-06-04 2012-06-13 基因组股份公司 Microorganisms for the production of 1,4-butanediol and related methods
CN102781926A (en) * 2010-02-11 2012-11-14 梅塔玻利克斯公司 Process for gamma-butyrolactone production
US20140030779A1 (en) * 2012-06-04 2014-01-30 Genomatica, Inc. Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
US20140170714A1 (en) * 2011-08-10 2014-06-19 Metabolix, Inc. Post process purification for gamma-butyrolactone production
US20140371417A1 (en) * 2013-04-26 2014-12-18 Genomatica, Inc. Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
CN105647912A (en) * 2014-12-01 2016-06-08 清华大学 Acid resistance expression cassette and screening method thereof
US20160264978A1 (en) * 2011-06-22 2016-09-15 Genomatica, Inc. Microorganisms for producing 1,4-butanediol and methods related thereto
US20190276863A1 (en) * 2009-11-25 2019-09-12 Genomatica, Inc. Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101381002B1 (en) * 2012-04-23 2014-04-04 동국대학교 산학협력단 Method for gamma-aminobutyric acid with glycerol as substrate by biotransformation process
US9920339B2 (en) * 2014-06-16 2018-03-20 Invista North America S.A.R.L. Methods, reagents and cells for biosynthesizing compounds
WO2015195707A1 (en) * 2014-06-16 2015-12-23 Invista Technologies S.A.R.L. Methods, reagents and cells for biosynthesizing compounds
CN116083329A (en) * 2022-09-26 2023-05-09 北京绿色康成生物技术有限公司 Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101668861A (en) * 2007-03-16 2010-03-10 基因组股份公司 compositions and methods for the biosynthesis of 1,4-butanediol and its precursors
US20100112654A1 (en) * 2008-09-10 2010-05-06 Burk Mark J Microorganisms for the production of 1,4-butanediol
US20110014669A1 (en) * 2009-01-23 2011-01-20 Microbia, Inc. Production of 1,4 Butanediol in a Microorganism
CN102498215A (en) * 2009-06-04 2012-06-13 基因组股份公司 Microorganisms for the production of 1,4-butanediol and related methods
CN113528417A (en) * 2009-06-04 2021-10-22 基因组股份公司 Microorganisms for producing 1, 4-butanediol and related methods
US20110129899A1 (en) * 2009-10-13 2011-06-02 Robert Haselbeck Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto
US20190276863A1 (en) * 2009-11-25 2019-09-12 Genomatica, Inc. Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone
CN102781926A (en) * 2010-02-11 2012-11-14 梅塔玻利克斯公司 Process for gamma-butyrolactone production
US20160264978A1 (en) * 2011-06-22 2016-09-15 Genomatica, Inc. Microorganisms for producing 1,4-butanediol and methods related thereto
US20140170714A1 (en) * 2011-08-10 2014-06-19 Metabolix, Inc. Post process purification for gamma-butyrolactone production
US20140030779A1 (en) * 2012-06-04 2014-01-30 Genomatica, Inc. Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
US20140371417A1 (en) * 2013-04-26 2014-12-18 Genomatica, Inc. Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
CN105647912A (en) * 2014-12-01 2016-06-08 清华大学 Acid resistance expression cassette and screening method thereof

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
JAE WOONG CHOI等: "Enhanced production of gamma-aminobutyrate(GABA) in recombinant Corynebacterium glutamicum by expressing glutamate decarboxylase active in expanded pH range", 《MICROBIAL CELL FACTORIES》, vol. 14, no. 21, 15 February 2015 (2015-02-15), pages 2, XP021211597, DOI: 10.1186/s12934-015-0205-9 *
JIAN WANG等: "Bacterial synthesis of C3-C5 diols via extending amino acid catabolism", 《PNAS》, vol. 117, no. 32, 27 July 2020 (2020-07-27), pages 19160 - 19163 *
无: "GenBank: HBP9016664.1", 《GENBANK》, 1 February 2022 (2022-02-01) *
无: "GenBank: PNG88356.1", 《GENBANK》, 18 January 2018 (2018-01-18) *
无: "NCBI Reference Sequence: WP_001058802.1", 《GENBANK》, 13 March 2021 (2021-03-13) *
无: "NCBI Reference Sequence: WP_001087611.1", 《GENBANK》, 16 December 2020 (2020-12-16) *
无: "NCBI Reference Sequence:005082584.1", 《GENBANK》, 7 January 2020 (2020-01-07) *
无: "NCBI Reference Sequence:WP_ 011013682.1", 《GENBANK》, 25 May 2020 (2020-05-25) *
无: "NCBI Reference Sequence:WP_003234549.1", 《GENBANK》, 10 July 2019 (2019-07-10) *
无: "NCBI Reference Sequence:WP_011730755.1", 《GENBANK》, 6 January 2020 (2020-01-06) *
无: "NCBI Reference Sequence:WP_012393886.1", 《GENBANK》, 15 June 2019 (2019-06-15) *
无: "UniProtKB/Swiss-Prot:Q6RKB1.1", 《GENBANK》, 25 May 2022 (2022-05-25) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024066822A1 (en) * 2022-09-26 2024-04-04 北京绿色康成生物技术有限公司 METHOD FOR PRODUCING γ-BUTYROLACTONE OR 1,4-BUTANEDIOL BY FERMENTATION
CN117089507A (en) * 2023-09-28 2023-11-21 北京化工大学 A genetically engineered Escherichia coli strain that uses cheap carbon sources to synthesize 1,4-butanediol and its application
WO2025135685A1 (en) * 2023-12-21 2025-06-26 대상 주식회사 Mutant microorganism having improved ability to produce 1,4-butanediol and method for producing 1,4-butanediol using same
WO2025136008A1 (en) * 2023-12-21 2025-06-26 대상 주식회사 Mutant microorganism having improved ability to produce 1,4-butanediol and method for producing 1,4-butanediol using same

Also Published As

Publication number Publication date
WO2024066822A1 (en) 2024-04-04

Similar Documents

Publication Publication Date Title
CN116083329A (en) Method for producing gamma-butyrolactone or 1,4-butanediol by fermentation
CN101389752B (en) Bacteria capable of producing organic acids and method for producing organic acids
KR100511734B1 (en) Method for producing optically active compound
WO2023240794A1 (en) Recombinant escherichia coli for producing l-homoserine and use thereof
CN105950529B (en) Recombinant corynebacterium glutamicum producing 3-hydroxypropionic acid, and construction method and application thereof
CN105368766A (en) Genetically engineered bacterium for producing pentamethylene diamine and method for preparing pentamethylene diamine
CN113234611A (en) Saccharomyces cerevisiae engineering bacteria and application thereof in preparation of protocatechuic acid
US10760104B2 (en) Method of producing D-xylonate and coryneform bacterium
WO2010032698A1 (en) Method for producing lactic acid from plant-derived raw material, and lactic-acid-producing bacterium
CN116064345A (en) High-efficiency production of fucosyllactose without genetically engineered bacteria and its application
CN117844728B (en) A L-valine production strain and its construction method and application
CN108085288B (en) Method for producing 1, 3-propylene glycol by utilizing recombinant microorganism fermentation
KR20210037448A (en) Mass production method for poly(3-hydroxypropionate)
KR100447532B1 (en) (R)-Hydroxycarboxylic Acid Producing Recombinant Microorganism and Process for Preparing (R)-Hydroxycarboxylic Acid Using the Same
CN116396914A (en) Method for producing 3-hydroxy propionic acid and acrylic acid by fermentation
KR20070096347A (en) 4―hydroxybutyrate (4HB) Variant and Production Method of 4HB Using the Same
DE10312775B4 (en) Method and microorganism for the microbial production of L-alanine
WO2011034031A1 (en) Isopropyl alcohol-producing bacterium and method for producing isopropyl alcohol
KR102782737B1 (en) Novel CoA-acylating propionaldehyde dehydrogenase variant and uses thereof
CN118165907B (en) Gamma-aminobutyric acid production strain and construction method and application thereof
CN115851566B (en) Strain for producing 2-pyrrolidone by one-step method and application thereof
KR102377745B1 (en) Novel promoter and use thereof
KR102598992B1 (en) Isobutanol and polyhydroxybutyrate simultaneous production strain and use thereof
US12312608B2 (en) D-xylose dehydrogenase from coryneform bacteria and process for preparing D-xylonate
KR20240147934A (en) Mutant microorganism producing 1,4-butanediol and method for producing 1,4-butanediol using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20230509

WD01 Invention patent application deemed withdrawn after publication